The Case Against a SpaceX and Tesla Merger
Yahoo · 30 de oct de 2026
The market is getting excited about a potential merger, but now may not be the right time for Tesla shareholders to get the best deal.
Danaher Corp
DHR
Sí, existe CEDEAR de DHR en Argentina. Operás bajo el ticker DHR en BYMA, con ratio 54:1 respecto a la acción en NYSE. Ratios y calculadora Ver próximos dividendos.
Empresa subyacente
HealthcareDiagnostics & Research
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
- País
- United States
- Empleados
- 58.000
- Sitio web
- danaher.com
Precio histórico
No hay suficientes datos históricos para mostrar el gráfico de DHR.
Cotización y datos
NYSERatio 54:1 · Subyacente DHR
CEDEAR (ARS)
Precio
$ 7.110
Var. %
-1,39%
Volumen operado
2.396
Subyacente (USD)
Precio DHR
US$ 232,23
Teórico (precio / ratio)
DHR ÷ 54
US$ 4,30
Dólar MEP (DHRD)
Dividendos
Yield y fechas del subyacente vía Yahoo Finance. Ver calendario de dividendos.
Yield (USD)
0,7 %
Frecuencia (estimada)
Trim.
Próxima ex-date
sin fecha
Próximo pago
sin fecha
Cobro estimado (anual)
Dividendo anual USD ÷ ratio 54
USD 0,03
Preguntas frecuentes
¿Existe CEDEAR de DHR en Argentina?
Sí, existe el CEDEAR de DHR (Danaher Corp) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es DHR.
¿Cuál es el ticker del CEDEAR de Danaher Corp?
El ticker del CEDEAR de Danaher Corp en Argentina es DHR. La acción subyacente cotiza en NYSE con el símbolo DHR.
¿Cuál es el ratio del CEDEAR DHR?
El CEDEAR DHR tiene un ratio de 54:1. Eso significa que 54 CEDEARs equivalen a 1 acción de DHR.
¿Cuánto vale el CEDEAR DHR hoy?
El CEDEAR DHR cotiza hoy a $ 7.110 en pesos argentinos, con una variación diaria de -1,39%.
¿Cuánto vale la acción DHR en dólares?
CEDEARs similares
Otros CEDEARs de Salud.
Noticias
Repligen Soars 5% as RBC Raises Price Target to $200 After Full-Year Guidance Hike
Yahoo · 29 de oct de 2026
Key TakeawaysRepligen shares rose 5% after RBC Capital raised its price target to $200, a day after the company beat estimates and raised its full-year revenue…
